STONY BROOK N.Y., September 25, 2018 – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) announced today that it is launching an additional system to tag the industry’s larger volume cannabis or hemp grows as part of TheraCann International’s ETCH Biotrace™ solution. On the heels of its successful showing of its first [...]
The incidences of counterfeiting continue to escalate–rising from $1.2 trillion in 2017 to an anticipated $1.82 trillion by 2020. Years of technological advancement have made it harder to spot inauthentic products. As a result, consumers are increasingly deceived into purchasing inferior or inauthentic goods. Such products may have been produced using substandard components or in [...]
Chemical Knowledge Hub | LineaRx signs development agreement with Takis and Evvivax for linear-DNA based anti-cancer vaccines
21/09/2018 Applied DNA Sciences announced yesterday that LineaRx, its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with Takis and Evvivax, biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively.
LineaRx, a subsidiary of molecular technology company Applied DNA Sciences, has entered into a joint development agreement with Italian biotech Takis over developing DNA-based anti-cancer vaccines for humans. The agreement also includes an alliance with Evvivax, a Takis company, related to the discovery and development of similar vaccines for the veterinary market. [...]
To decrease the threat of counterfeit products in different industries, Applied DNA Sciences has introduced a biochemistry-based innovation in apparel authentication. By partnering with North Carolina–based thread manufacturer American & Efird LLC ( A&E), Applied DNA Sciences unveiled a DNA-tagged thread that includes a DNA marker, which can test authenticity by adding a small amount of activator [...]
Published: Sep 20, 2018 By Mark Terry LineaRx, a subsidiary of Applied DNA Sciences, has entered into a Joint Development Agreement with Takis SRL and Evvivax SLR. They will focus on developing anti-cancer vaccines. Under the terms of the deal, LineaRx and Takis and Evvivax will work together to develop linear DNA expression vectors of two of Takis/Evvivax’s [...]
Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines
STONY BROOK N.Y., September 20, 2018 – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) announced today that LineaRx, Inc. (“LineaRx”), its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement (the “Agreement”) with Takis S.R.L. and Evvivax S.R.L. (“Takis/Evvivax”), biotechnology companies focused on the discovery [...]
Chain reaction: With an eye on exploding biotherapeutic fields, Stony Brook-based Applied DNA Sciences has spun its DNA-manufacturing business into a new company, LineaRx.
Applied DNA Forms Wholly Owned Subsidiary, LineaRx, to Develop Large-Scale, PCR-Produced DNA for Biotherapeutics
STONY BROOK N.Y., September 18, 2018 – Applied DNA Sciences Inc., (NASDAQ: APDN, “Applied DNA” or the “Company”), the leader in large-scale PCR-based DNA manufacturing, announced today the formation of LineaRx, Inc., a wholly owned subsidiary. Its purpose is to commercialize the Company’s extensive experience in the design, manufacture and chemical modification [...]
Planning for Sustainable Systems in an Accelerated Acquisition Environment December 3-6, 2018 Nashville, TN Booth 400